We found that Fgfr3 activation in immature OBs and hypertrophic CCs not only perturbed hypertrophic cells in the growth plate (thus affecting long bone growth) but also led to osteopenia in adult (3-month-old) mice but not in growing (3-week-old mice). Here, FGFR3 is linked to Osteopenia.